EBV BRLF1 disrupts RIG-I signaling to promote viral and tumour immune escape and contributes to a tumour permissive microenvironment, it is an important mechanism EBV uses to prevent RIG-I activation during early lytic cycle. Here, RIGI is linked to neoplasm.